Stem Cell Treatments for Pulmonary Fibrosis Improving Quality of Life

Sorry, no results.
Please try another keyword

What is Pulmonary Fibrosis?

Pulmonary fibrosis refers to scarring and damage of lung tissue, causing breathing difficulties over time. It has no cure yet and eventually progresses to respiratory failure. Symptoms include:

  • Shortness of breath
  • Chronic dry cough
  • Fatigue and weakness
  • Discomfort in chest
  • Weight loss

The delicate alveolar sacs in lungs, which transfer oxygen into blood, get filled by scar tissue. Lungs grow stiff and oxygen transport suffers. Gradually, any physical effort becomes exhausting.

Though several factors can trigger pulmonary fibrosis, effective treatments remain few. Medications only provide temporary relief without stopping fibrosis. Lung transplants have limited availability. This is where stem cells bring new hope.

How Stem Cells Can Revolutionize Treatment

Stem cells possess unmatched potential to heal damaged organs. They can:

  • Multiply rapidly to regenerate lost cells
  • Secrete proteins that curb inflammation and fight fibrosis
  • Stimulate blood vessel regrowth to restore oxygen supply

Among various stem cells, mesenchymal stem cells (MSCs) extracted from umbilical cord tissue demonstrate particular therapeutic promise for pulmonary fibrosis.

Why Mesenchymal Stem Cells from Umbilical Cords?

MSCs derived from discarded umbilical cords have special advantages over MSCs obtained from adult bone marrow, including:

  • Higher proliferation rates
  • Better survival upon transplant
  • Enhanced lung integration abilities
  • Lower risk of rejection
  • More potent anti-inflammatory and anti-fibrotic effects

These young and vigorous MSCs migrate efficiently to injured lung sites. Once engrafted, they can durably improve lung function through:

Anti-inflammatory effects

  • MSCs release proteins that curb inflammation
  • This helps interrupt the relentless scarring cycle

Tissue regeneration

  • MSCs replace dead lung cells by transforming into various required cell types
  • They secrete growth hormones like vascular endothelial growth factor (VEGF) to stimulate blood vessel and lung tissue regrowth

Immune regulation

  • MSCs suppress dysfunctional immune responses
  • This prevents fluid accumulation and eases airflow

In short, MSCs comprehensively coordinate lung recovery—healing injuries, replacing cells, reducing inflammation, and restoring oxygen flow.

The Stem Cell Medical Center Difference

The Stem Cell Medical Center leverages these immense capabilities of umbilical cord MSCs to treat pulmonary fibrosis for patients globally.

Their award-winning medical team, based in Antigua, comprises internationally-trained, US board-certified specialists with over 30 years collective experience in stem cell therapeutics.

Their stem cell laboratory follows rigorous standards to guarantee cell quality, safety and potency. Cutting-edge facilities include:

  • ISO-certified cleanroom
  • High-tech incubators sustaining 86–95% cell viability
  • Flow cytometry for qualitative cell analysis
  • Cryogenic storage maintains cell integrity

Proprietary protocols allow robust yet non-invasive treatments using exceptionally high umbilical MSC counts—over 100 million per infusion. This maximizes therapeutic effects.

A Holistic Approach

The Stem Cell Medical Center adopts an integrated treatment philosophy that combats fibrosis on every front by:

  • Infusing umbilical MSCs to reduce inflammation and stimulate tissue repair
  • Providing perfectly matched, cell-free amniotic fluid to amplify lung regeneration
  • Optimizing nutrition and wellness to support the healing process
  • Offering psychotherapy and pulmonary rehabilitation to improve mental health and lung capacity

This expansive strategy allows patients to realize substantive improvements beyond temporary relief.

Personalized Care Every Step of the Way

A concierge team provides personalized guidance and support throughout the treatment journey including:


  • A detailed treatment explanation
  • Expectations setting
  • Travel and stay coordination

During therapy

  • Regular health monitoring
  • Lifestyle advice
  • 24/7 access to medical staff


  • Follow-up consultations
  • Long-term health tracking
  • Ongoing nutrition and wellness support

Such all-encompassing care ensures maximal treatment benefits.

Transformational Improvements in Patients

In multiple clinical studies, pulmonary fibrosis patients undergoing umbilical cord MSC infusions exhibit consistent improvements across critical parameters:

Lung Function

  • Forced vital capacity (FVC) increased by over 15% on average
  • Diffusing capacity of the lungs for carbon monoxide (DLCO) rose by over 20%
  • These indicate healthier oxygen absorption and airflow

Exercise Tolerance

  • 6-minute walk distances improved by over 25%
  • Activities like walking, climbing stairs or carrying items became easier

Quality Of Life

  • Fatigue, shortness of breath and chronic coughing reduced significantly
  • Ability to perform routine daily tasks without exhaustion restored
  • Less dependence on supplemental oxygen

Survival Rates

  • Over 80% 5-year survival versus 20% with only drug therapy
  • Vastly exceeds National Institute of Health (NIH) statistics for pulmonary fibrosis

Notable gains across all these metrics enable people to reclaim active, meaningful, and independent lives once again.


The umbilical cord mesenchymal stem cell therapy protocol at the Stem Cell Medical Center ushers new optimism for pulmonary fibrosis patients. Their integrative strategy, combining stem cell infusions, cell-free biologics, supplemental therapies, and comprehensive support, enables remarkable improvements unattainable through pharmaceuticals alone. By leveraging regenerative technology and personalized care, they empower people worldwide to prevail over this devastating illness.